Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs.

Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics.

Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise.

We work with some of the most interesting and loyal partners and customers from across the world in the pharmaceutical and biotech industry as well as academia. Through a constant focus on high quality, scientific excellence, speed and solid teamwork, we have established ourselves as a highly professional and competent partner in the market.

Biotechnology

Gubra

Anne-Marie Levy Rasmussen

Jacob Tórsheim Voltelen

Kristoffer Rigbolt

Kristian Borbos

Trine Nygaard Hamann

Mette Paasch Liljedahl

Henrik Björk Hansen

Sebastian Tølbøl Thrane

Jes Jørgensen

Frederik Friis-Hansen

Michael Christensen

Michael Feigh

Simone Sparholt

Sofia Pitt Boserup

Martin Kræmer

The Research and Scientific Development team at Gubra is dedicated to advancing the company's proprietary early target and drug discovery programs and supporting preclinical contract research services. Specializing in metabolic diseases such as obesity, diabetes, and NASH, the team leverages expertise in peptide chemistry, pharmacology, imaging, and bioinformatics. They conduct in-depth studies using advanced techniques like NGS and AI technology to drive scientific innovation and deliver high-quality research outcomes for global pharmaceutical, biotech partners, and academic collaborators.

Research and Scientific Development

The Leadership Team at Gubra is responsible for steering the company's strategic direction and ensuring operational excellence. Comprising key executives, such as the CEO, CTO, CFO, COO, and other principal scientists and VPs, the team collaboratively makes high-level decisions, drives scientific innovation, manages business relationships, and upholds the company's commitment to quality and scientific excellence in both its CRO services and proprietary drug discovery programs.

Leadership Team

The Research & Development team at Gubra is dedicated to advancing the company's proprietary early target and drug discovery programs, with a strong focus on metabolic diseases such as obesity, diabetes, NASH, and gastrointestinal disorders. This multidisciplinary team, including experts in pharmacology, computational biology, chemistry, bioanalysis, and imaging, works collaboratively to design and execute high-quality research projects. They leverage state-of-the-art techniques in peptide chemistry, in vivo and ex vivo assays, molecular pharmacology, and bioinformatics to drive scientific innovation and support the development of novel therapeutics.

Research & Development

Gubra

Org chart

Teams

Research and Scientific Development

Leadership Team

Research & Development

Offices

Gubra

Org chart

Teams

Research and Scientific Development

Leadership Team

Research & Development

Offices

Related companies